药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sibutramine
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lofexidine.
Sibutramine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Lofexidine.
Sibutramine
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Lofexidine.
Sibutramine
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Lofexidine.
Sibutramine
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Lofexidine.
Sibutramine
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Lofexidine.
Sibutramine
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Lofexidine.
Sibutramine
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Lofexidine.
Sibutramine
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Lofexidine.
Sibutramine
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Lofexidine.
Sibutramine
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Lofexidine.
Sibutramine
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Lofexidine.
Sibutramine
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Lofexidine.
Sibutramine
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Lofexidine.
Sibutramine
Triclabendazole
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Lofexidine.
Sibutramine
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Lofexidine.
Sibutramine
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Lofexidine.
Sibutramine
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Lofexidine.
Sibutramine
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Lofexidine.
Sibutramine
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Lofexidine.